I think thats low-hanging fruit that we could really get better at, in terms of rehab
Promise, Not Proof Im open to the idea that maybe someday well find a benefit, Dr Nadolsky says, but right now
None of this progress would have been possible without the more than 39,000 people who took part in Parkinsons clinical trials around the world over the past decade, helping to move us closer to better symptomatic treatments and, ultimately, disease-modifying therapies
Research shows this small molecule is an inhibitor of nicotinamide N-methyltransferase (NNMT), an enzyme involved in cellular energy regulation and fat metabolism
Related articles Related Qustion The mechanism of action of Dihexa Dec 17, 2024 Dihexa has become a pioneering peptide drug that can address neurodegenerative diseases, including Alzheimer's disease
Obstructive sleep apnea and the metabolic syndrome: the road to clinically-meaningful phenotyping, improved prognosis, and personalized treatment